Risk Factors for Thrombosis, Overshunting and Death in Infants after Modified Blalock-Taussig Shunt
Background: The Modified Blalock-Taussig shunt procedure can provide increased flow of blood to the lungs for babies born with certain congenital heart defects. We evaluated 44 subjects under 2 years of age who had a Modified Blalock-Taussig shunt (MBTS) procedure performed from 2009-2013, to invest...
Saved in:
Published in | Acta Cardiologica Sinica Vol. 32; no. 3; pp. 337 - 342 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
台灣
中華民國心臟學會
01.05.2016
Taiwan Society of Cardiology |
Subjects | |
Online Access | Get full text |
ISSN | 1011-6842 |
DOI | 10.6515/ACS20150731A |
Cover
Abstract | Background: The Modified Blalock-Taussig shunt procedure can provide increased flow of blood to the lungs for babies born with certain congenital heart defects. We evaluated 44 subjects under 2 years of age who had a Modified Blalock-Taussig shunt (MBTS) procedure performed from 2009-2013, to investigate risk factors for thrombosis, overshunting and death. Methods: The study subjects included in our investigation were severely cyanotic newborns with pulmonary stenosis or atresia and duct dependent circulation, and infants having Tetralogy of Fallot with small pulmonary arteries who underwent a MBTS procedure in our facility from 2009-2013. We duly noted patient preoperative characteristics such as hemoglobin, hematocrit, mean platelet volume, prothrombin time and partial thromboplastin time. Our study investigated the risk factors for post-operative overcirculation, thrombosis and death. Results: The age and weight of patients in our study at the time of procedure ranged from 1 day to 20 months old (median 12 days), and 2.4 kg to 12 kg (mean 4.6 kg), respectively. A total of 8 patients died following surgery, and. 4 (9.1%) had shunt thrombosis, of which one died during shunt revision. Partial thromboplastin time was 28.7 seconds in patients with thrombosis, and 35 in all other patients (p = 0.04). Overcirculation was detected in 5 patients; shunt size/body weight was 1.25 in patients who had overcirculation, and 1.06 in all other patients. Conclusions: It is important to assess risk factors associated with the MBTS operation. The results of our study suggest that a preoperative low aPTT value may be an indicator for thrombosis in infants who have undergone MBTS surgery. |
---|---|
AbstractList | Background: The Modified Blalock-Taussig shunt procedure can provide increased flow of blood to the lungs for babies born with certain congenital heart defects. We evaluated 44 subjects under 2 years of age who had a Modified Blalock-Taussig shunt (MBTS) procedure performed from 2009-2013, to investigate risk factors for thrombosis, overshunting and death. Methods: The study subjects included in our investigation were severely cyanotic newborns with pulmonary stenosis or atresia and duct dependent circulation, and infants having Tetralogy of Fallot with small pulmonary arteries who underwent a MBTS procedure in our facility from 2009-2013. We duly noted patient preoperative characteristics such as hemoglobin, hematocrit, mean platelet volume, prothrombin time and partial thromboplastin time. Our study investigated the risk factors for post-operative overcirculation, thrombosis and death. Results: The age and weight of patients in our study at the time of procedure ranged from 1 day to 20 months old (median 12 days), and 2.4 kg to 12 kg (mean 4.6 kg), respectively. A total of 8 patients died following surgery, and. 4 (9.1%) had shunt thrombosis, of which one died during shunt revision. Partial thromboplastin time was 28.7 seconds in patients with thrombosis, and 35 in all other patients (p = 0.04). Overcirculation was detected in 5 patients; shunt size/body weight was 1.25 in patients who had overcirculation, and 1.06 in all other patients. Conclusions: It is important to assess risk factors associated with the MBTS operation. The results of our study suggest that a preoperative low aPTT value may be an indicator for thrombosis in infants who have undergone MBTS surgery. The Modified Blalock-Taussig shunt procedure can provide increased flow of blood to the lungs for babies born with certain congenital heart defects. We evaluated 44 subjects under 2 years of age who had a Modified Blalock-Taussig shunt (MBTS) procedure performed from 2009-2013, to investigate risk factors for thrombosis, overshunting and death. The study subjects included in our investigation were severely cyanotic newborns with pulmonary stenosis or atresia and duct dependent circulation, and infants having Tetralogy of Fallot with small pulmonary arteries who underwent a MBTS procedure in our facility from 2009-2013. We duly noted patient preoperative characteristics such as hemoglobin, hematocrit, mean platelet volume, prothrombin time and partial thromboplastin time. Our study investigated the risk factors for post-operative overcirculation, thrombosis and death. The age and weight of patients in our study at the time of procedure ranged from 1 day to 20 months old (median 12 days), and 2.4 kg to 12 kg (mean 4.6 kg), respectively. A total of 8 patients died following surgery, and. 4 (9.1%) had shunt thrombosis, of which one died during shunt revision. Partial thromboplastin time was 28.7 seconds in patients with thrombosis, and 35 in all other patients (p = 0.04). Overcirculation was detected in 5 patients; shunt size/body weight was 1.25 in patients who had overcirculation, and 1.06 in all other patients. It is important to assess risk factors associated with the MBTS operation. The results of our study suggest that a preoperative low aPTT value may be an indicator for thrombosis in infants who have undergone MBTS surgery. The Modified Blalock-Taussig shunt procedure can provide increased flow of blood to the lungs for babies born with certain congenital heart defects. We evaluated 44 subjects under 2 years of age who had a Modified Blalock-Taussig shunt (MBTS) procedure performed from 2009-2013, to investigate risk factors for thrombosis, overshunting and death.BACKGROUNDThe Modified Blalock-Taussig shunt procedure can provide increased flow of blood to the lungs for babies born with certain congenital heart defects. We evaluated 44 subjects under 2 years of age who had a Modified Blalock-Taussig shunt (MBTS) procedure performed from 2009-2013, to investigate risk factors for thrombosis, overshunting and death.The study subjects included in our investigation were severely cyanotic newborns with pulmonary stenosis or atresia and duct dependent circulation, and infants having Tetralogy of Fallot with small pulmonary arteries who underwent a MBTS procedure in our facility from 2009-2013. We duly noted patient preoperative characteristics such as hemoglobin, hematocrit, mean platelet volume, prothrombin time and partial thromboplastin time. Our study investigated the risk factors for post-operative overcirculation, thrombosis and death.METHODSThe study subjects included in our investigation were severely cyanotic newborns with pulmonary stenosis or atresia and duct dependent circulation, and infants having Tetralogy of Fallot with small pulmonary arteries who underwent a MBTS procedure in our facility from 2009-2013. We duly noted patient preoperative characteristics such as hemoglobin, hematocrit, mean platelet volume, prothrombin time and partial thromboplastin time. Our study investigated the risk factors for post-operative overcirculation, thrombosis and death.The age and weight of patients in our study at the time of procedure ranged from 1 day to 20 months old (median 12 days), and 2.4 kg to 12 kg (mean 4.6 kg), respectively. A total of 8 patients died following surgery, and. 4 (9.1%) had shunt thrombosis, of which one died during shunt revision. Partial thromboplastin time was 28.7 seconds in patients with thrombosis, and 35 in all other patients (p = 0.04). Overcirculation was detected in 5 patients; shunt size/body weight was 1.25 in patients who had overcirculation, and 1.06 in all other patients.RESULTSThe age and weight of patients in our study at the time of procedure ranged from 1 day to 20 months old (median 12 days), and 2.4 kg to 12 kg (mean 4.6 kg), respectively. A total of 8 patients died following surgery, and. 4 (9.1%) had shunt thrombosis, of which one died during shunt revision. Partial thromboplastin time was 28.7 seconds in patients with thrombosis, and 35 in all other patients (p = 0.04). Overcirculation was detected in 5 patients; shunt size/body weight was 1.25 in patients who had overcirculation, and 1.06 in all other patients.It is important to assess risk factors associated with the MBTS operation. The results of our study suggest that a preoperative low aPTT value may be an indicator for thrombosis in infants who have undergone MBTS surgery.CONCLUSIONSIt is important to assess risk factors associated with the MBTS operation. The results of our study suggest that a preoperative low aPTT value may be an indicator for thrombosis in infants who have undergone MBTS surgery. |
Author | Rahmi Özdemir Önder Doksöz Osman Nejat Sarıosmanoğlu Mustafa Karaçelik Yılmaz Yozgat Timur Meşe Cem Karadeniz Mehmet Küçük |
AuthorAffiliation | 2 Department of Pediatric Cardiovascular Surgery, Dr. Behçet Uz Children’s Hospital, Izmir, Turkey 1 Department of Pediatric Cardiology |
AuthorAffiliation_xml | – name: 1 Department of Pediatric Cardiology – name: 2 Department of Pediatric Cardiovascular Surgery, Dr. Behçet Uz Children’s Hospital, Izmir, Turkey |
Author_xml | – sequence: 1 fullname: Mehmet Küçük – sequence: 2 fullname: Rahmi Özdemir – sequence: 3 fullname: Mustafa Karaçelik – sequence: 4 fullname: Önder Doksöz – sequence: 5 fullname: Cem Karadeniz – sequence: 6 fullname: Yılmaz Yozgat – sequence: 7 fullname: Timur Meşe – sequence: 8 fullname: Osman Nejat Sarıosmanoğlu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27274175$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkc1v1DAQxX0ooqX0xhEhHzkQ8LedC9KytLRSUSW6nC0nmWzcZu3WTor2v69XuyA6l9HovXkjze8NOgoxAELvKPmsJJVfFstbRqgkmtPFETqhhNJKGcGO0VnOd6SUIIQq_RodM820oFqeoPaXz_f4wrVTTBn3MeHVkOKmidnnT_jmCVIe5jD5sMYudPg7uGnAPuCr0LswZez6CRL-GTvfe-jwt9GNsb2vVm7O2a_x7W75LXrVuzHD2aGfot8X56vlZXV98-NqubiuHJdsqoRitCZG1L3UjezBcV5LQg1xkjaU18owo6FIAKZRjjTQ9ppICbxRSjaMn6Kv-9yHudlA10KYkhvtQ_Ibl7Y2Om9fKsEPdh2frDBGaLUL-HgISPFxhjzZjc8tjKMLEOdsqa6l0ULIulg__H_r35G_ny2G93vDsP0DjR22CVxnCwNaM26KfLmXnU9-8vYuzimU59gdth01W1gqIg-NqYKPvhw415YLxp8BCSKX2g |
ContentType | Journal Article |
DBID | 188 9RA NPM 7X8 5PM |
DOI | 10.6515/ACS20150731A |
DatabaseName | 華藝線上圖書館中文電子期刊 (Chinese Electronic Periodical Services (CEPS))(Journals學術期刊資料庫) HyRead台灣全文資料庫 PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EndPage | 342 |
ExternalDocumentID | PMC4884762 27274175 00419238 10116842_201605_201605260001_201605260001_337_342 |
Genre | Journal Article |
GroupedDBID | --- 188 23M 2UF 53G 5GY 9RA ACGFS AENEX AINHJ ALMA_UNASSIGNED_HOLDINGS ATFKH CEFSP CNMHZ DIK HYE OK1 RPM TUXDW UZ5 8RM ABJNI C45 LMWXZ OVD TEORI NPM 7X8 5PM |
ID | FETCH-LOGICAL-a352t-462190849f57b5fea33950180a51b13968287e7b5ee8b6a0becf7055e3b665b23 |
ISSN | 1011-6842 |
IngestDate | Thu Aug 21 18:16:33 EDT 2025 Thu Sep 04 23:07:41 EDT 2025 Wed Feb 19 02:08:30 EST 2025 Thu Jul 31 12:06:37 EDT 2025 Tue Oct 01 22:51:09 EDT 2024 |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 3 |
Keywords | Shunt thrombosis Risk factors Activated partial thromboplastin time |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-a352t-462190849f57b5fea33950180a51b13968287e7b5ee8b6a0becf7055e3b665b23 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 This paper has been presented as an oral presentation at the 10th International Congress of Update in Cardiology and Cardiovascular Surgery, Kaya Plazzo Convention Center, March 13-16, 2014 / Antalya, Turkey. |
PMID | 27274175 |
PQID | 1795874459 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4884762 proquest_miscellaneous_1795874459 pubmed_primary_27274175 hyweb_hyread_00419238 airiti_journals_10116842_201605_201605260001_201605260001_337_342 |
PublicationCentury | 2000 |
PublicationDate | 20160501 201605 2016-May |
PublicationDateYYYYMMDD | 2016-05-01 |
PublicationDate_xml | – month: 05 year: 2016 text: 20160501 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | 台灣 |
PublicationPlace_xml | – name: 台灣 – name: China (Republic : 1949- ) |
PublicationTitle | Acta Cardiologica Sinica |
PublicationTitleAlternate | Acta Cardiol Sin |
PublicationYear | 2016 |
Publisher | 中華民國心臟學會 Taiwan Society of Cardiology |
Publisher_xml | – name: 中華民國心臟學會 – name: Taiwan Society of Cardiology |
References | 11922508 - Pediatr Cardiol. 2002 Jan-Feb;23(1):49-52 1692681 - Ann Thorac Surg. 1990 May;49(5):797-801 8675521 - J Cardiovasc Surg (Torino). 1996 Apr;37(2):149-52 23539419 - Eur J Cardiothorac Surg. 2013 Dec;44(6):1096-102 21550583 - Ann Thorac Surg. 2011 Aug;92(2):642-51; discussion 651-2 6830670 - Br Heart J. 1983 Apr;49(4):359-63 7586420 - Circulation. 1995 Nov 1;92(9 Suppl):II256-61 19874471 - J Thromb Haemost. 2010 Jan;8(1):146-7 18036938 - Ann Thorac Surg. 2007 Dec;84(6):2070-5; discussion 2070-5 20139195 - Interact Cardiovasc Thorac Surg. 2010 May;10 (5):727-31 21247392 - Curr Pharm Des. 2011;17(1):47-58 9240290 - J Thorac Cardiovasc Surg. 1997 Jul;114(1):25-30 16352089 - Heart Lung Circ. 2002;11(3):152-6 3968910 - J Thorac Cardiovasc Surg. 1985 Feb;89(2):275-9 23673075 - Ann Thorac Surg. 2013 Jul;96(1):176-82 17683985 - Heart Lung Circ. 2008 Feb;17(1):54-8 |
References_xml | – reference: 8675521 - J Cardiovasc Surg (Torino). 1996 Apr;37(2):149-52 – reference: 21550583 - Ann Thorac Surg. 2011 Aug;92(2):642-51; discussion 651-2 – reference: 1692681 - Ann Thorac Surg. 1990 May;49(5):797-801 – reference: 7586420 - Circulation. 1995 Nov 1;92(9 Suppl):II256-61 – reference: 9240290 - J Thorac Cardiovasc Surg. 1997 Jul;114(1):25-30 – reference: 23539419 - Eur J Cardiothorac Surg. 2013 Dec;44(6):1096-102 – reference: 18036938 - Ann Thorac Surg. 2007 Dec;84(6):2070-5; discussion 2070-5 – reference: 17683985 - Heart Lung Circ. 2008 Feb;17(1):54-8 – reference: 20139195 - Interact Cardiovasc Thorac Surg. 2010 May;10 (5):727-31 – reference: 23673075 - Ann Thorac Surg. 2013 Jul;96(1):176-82 – reference: 21247392 - Curr Pharm Des. 2011;17(1):47-58 – reference: 16352089 - Heart Lung Circ. 2002;11(3):152-6 – reference: 19874471 - J Thromb Haemost. 2010 Jan;8(1):146-7 – reference: 6830670 - Br Heart J. 1983 Apr;49(4):359-63 – reference: 3968910 - J Thorac Cardiovasc Surg. 1985 Feb;89(2):275-9 – reference: 11922508 - Pediatr Cardiol. 2002 Jan-Feb;23(1):49-52 |
SSID | ssj0000400167 ssib016529507 ssib028553345 ssib004300060 ssib038076208 ssib018830194 |
Score | 2.1052349 |
Snippet | Background: The Modified Blalock-Taussig shunt procedure can provide increased flow of blood to the lungs for babies born with certain congenital heart... The Modified Blalock-Taussig shunt procedure can provide increased flow of blood to the lungs for babies born with certain congenital heart defects. We... |
SourceID | pubmedcentral proquest pubmed hyweb airiti |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 337 |
SubjectTerms | Activated partial thromboplastin time Cadiovascular Surgery MEDLINE Original Risk factors SCI Scopus Shunt thrombosis |
Title | Risk Factors for Thrombosis, Overshunting and Death in Infants after Modified Blalock-Taussig Shunt |
URI | https://www.airitilibrary.com/Article/Detail/10116842-201605-201605260001-201605260001-337-342 http://www.hyread.com.tw/hypage.cgi?HYPAGE=search/search_detail_new.hpg&dtd_id=3&sysid=00419238 https://www.ncbi.nlm.nih.gov/pubmed/27274175 https://www.proquest.com/docview/1795874459 https://pubmed.ncbi.nlm.nih.gov/PMC4884762 |
Volume | 32 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKkBAviI8B5UtG4m0Ekjh20seuMA2kgkQ7aW-R3dgk2ppM_XjY_gb-aO5st0mrIQEvaRrHdtX7-Xx3vg9C3s14YWCnE8EsylSQKJEFShgTKFh4mYlEYWKMHR5_E6dnyddzft7r_ep4La1X6sPs5ta4kv-hKjwDumKU7D9QdjsoPIB7oC9cgcJw_Ssa_0C_8BNfMQf9BaflopmrZukSB3xHl4vS14JwLscg76GF40ttrP-LqxA-borKoCh6fClhb7sIpnINS-Xn0QQ7d8XX4Wwl0UekqDzPPJrYwMot28Zz9-ORPX1P3b3ltmNdzttIa2wYiBv0y3fe3bKcV9sh5EK6_vqycp0xxsts5_jUXCzt0MLavt1gGKLTNWBEonUX9DwXrbR4HNhlyq3Rs9XZLYdlLkfMPufHiu6YgWI0idGGk7Jo2H0N6HY1tyiIU0zY46q17GXa3jTdIXfjNLWH_hvbj93XExuzYY_P_S92kRQ498fuzJhh2o8Fgo2sMD0VKD_lNeyMt2ky-w65HQln-pA88KoJHTqcPSI9XT8m98be-eIJmSHcqIcbBbjRFm7vaRdsFMBGLdhoVVMPNmrBRjdgo3tgoxZsh-Ts5PN0dBr4Gh2BBNF9FSQCtrwwSwaGp4obLRkbYI7IUPJIgXYhsKCChiatMyVkCCzDYAInzZQQXMXsKTmom1o_JzSOVMFVxmOWskSyTBZJqAVjqoiF4XHSJ0P3V-Z-CS7RPzFCOuSIq5D7D6y5EEa7XwA2OUviPjm0VMjLa9DJihzTzYGKk_XJ2w1VcuCveGgma92sYYp0wLFEBB_0yTNHpfzKJYLJN0Tuk3SHftsXMHf7bktdlTaHO-ybCbDDF38c8yW53y6WV-RgtVjr1yD_rtQbC8vfMLOkXg |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Risk+Factors+for+Thrombosis%2C+Overshunting+and+Death+in+Infants+after+Modified+Blalock-Taussig+Shunt&rft.jtitle=Acta+Cardiologica+Sinica&rft.au=K%C3%BC%C3%A7%C3%BCk%2C+Mehmet&rft.au=%C3%96zdemir%2C+Rahmi&rft.au=Kara%C3%A7elik%2C+Mustafa&rft.au=Doks%C3%B6z%2C+%C3%96nder&rft.date=2016-05-01&rft.issn=1011-6842&rft.volume=32&rft.issue=3&rft.spage=337&rft_id=info:doi/10.6515%2FACS20150731A&rft_id=info%3Apmid%2F27274175&rft.externalDocID=27274175 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fwww.airitilibrary.com%2Fjnltitledo%2F10116842-c.jpg |